Story perspectives

FDA Investigates Gluten Labeling for Better Consumer Protection

1/22/2026

26 5

Summary

Story summary

The U.S. Food and Drug Administration (FDA) opened an investigation into gluten labeling due to data gaps about adverse reactions.
The FDA seeks input from industry professionals and the public on labeling and cross-contamination.
Gluten triggers severe reactions for people with celiac disease and can cause discomfort in those with gluten intolerance.
FDA Commissioner Marty Makary emphasized the need for better policies to protect affected individuals and improve food choices.

1 of 1

Story summary

The U.S. Food and Drug Administration (FDA) opened an investigation into gluten labeling due to data gaps about adverse reactions.
The FDA seeks input from industry professionals and the public on labeling and cross-contamination.
Gluten triggers severe reactions for people with celiac disease and can cause discomfort in those with gluten intolerance.
FDA Commissioner Marty Makary emphasized the need for better policies to protect affected individuals and improve food choices.